Investigator's Brochure (IB) Table

Drugs

Drug Name Sort descending Drug Company IB Date Risk List Available?
ABT-267, ABT 333, ABT-450 and Ritonavir AbbVie June 2017
Bedaquiline (TMC207) Janssen Research & Development October 2019
Cemiplimab (REGN2810) Regeneron Pharmaceuticals, Inc. September 2021
Cenicriviroc Mesylate CVC (TBR-652) - New - New Allergan April 2022
Dapivirine (Vaginal Ring) International Partnership For Microbicides September 2021
Delamanid (OPC-67683) Otsuka June 2021
Dolutegravir (GSK1349572) - New - New ViiV Healthcare October 2022
Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) Merck July 2021
Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) Gilead Sciences December 2016 YES
Glecaprevir (ABT-493) and Pibrentasvir (ABT-530) AbbVie December 2018
GSK1265744 (Cabotegravir) - New - New ViiV Healthcare January 2023
Letermovir Merck October 2021
Pretomanid (PA-824) - New - New Global Alliance for TB Drug Development (TB Alliance) January 2023
Raltegravir (Isentress) Merck September 2017 YES
Remdesivir (Veklury) Gilead Sciences June 2021
Rilpivirine (TMC278, Edurant) Janssen Research & Development July 2022
Sofosbuvir/Velapatasvir (Epclusa) Gilead July 2016
Tecovirimat (TPOXX) - New - New SIGA Technologies, Inc. December 2022
Tenofovir Alafenamide/Elvitegravir CONRAD July 2019
Vorinostat (Zolinza) Merck August 2013

Vaccines

Vaccine Name Sort descending Vaccine Company IB Date Risk List Available?
VRC-HIVRGP096-00-VP (HIV-1 Trimer 4571 Vaccine) VRC/NIAID/NIH September 2022
VRC-HIVVCP0l 08-00-VP (FP8vl -rTTHC) VRC/NIAID/NIH February 2022